• Product NameDronedarone hydrochloride
• Brief DescriptionInhibitors
• Purification99.50%
• Biological ActivityDronedarone hydrochloride is an amiodarone analogue which has been shown an effective and promising treatment for Atrial fibrillation
• Target NameAdrenergic Receptor inhibitor; Calcium Channel inhibitor; Potassium Channel inhibitor; Sodium Channel inhibitor
• CAS No. 141625-93-6
• Calculated MW 593.22
• Formulation C31H44N2O5SHCl
• Storage 3 years -20˚C powder;2 years -80˚C in solvent;

• Research Area:Cardiovascular System
  SMILES:Cl.CCCCN(CCCC)CCCOC1=CC=C(C=C1)C(=O)C1=C(CCCC)OC2=C1C=C(NS(C)(=O)=O)C=C2
  Pathways:Neuroscience; Membrane transporter/Ion channel; GPCR/G Protein
  Receptor:Adrenergic Receptor; Calcium Channel; Potassium Channel; Sodium Channel
  Boling pt:683.9C?
  Melting pt:
  Solubility:Ethanol: 40 mg/mL (67.42 mM); DMSO: 80 mg/mL (134.85 mM)
  Appearance:White Powder
  Remark:For obtaining a higher solubility , please warm the tube at 37 ˚C and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20 ˚C for several month.

1. Iwamoto T, et al. Cardiovasc Hematol Disord Drug Targets. 2007 Sep;7(3):188-98.

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting